Cardiology
Study findings from Baskent University provide new insights into cardiology
Published in Cardiovascular Device Liability Week, July 20th, 2008
"Several studies have shown that some individuals exhibit a reduced or completely missing antiplatelet response to aspirin. The aim of this study is to investigate the effects of platelet reactivity despite aspirin therapy on CK-MB and cTnI levels after elective percutaneous coronary interventions despite 600 mg loading dose of clopidogrel. One hundred fourteen ( mean age 61.2 +/- 9.3 years, 78.1% male) patients...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week
More Articles from Cardiovascular Device Liability Week
- Heart Attack
Back From the Dead: Cardiac Arrest Victim Salutes His Rescuer - Medicare and Medicaid
Young Man With Severe Disabilities Wins Right to Services From State Enabling Him to Live At Home - Abbott
FDA Approves Abbott's XIENCE V Drug Eluting Stent - Abdominal Aortic Aneurysm
Studies from J.B. Dimick and colleagues reveal new findings on abdominal aortic aneurysm - Abdominal Aortic Aneurysm
Study data from University of Copenhagen update understanding of abdominal aortic aneurysm - Abdominal Aortic Aneurysm
Surgeons Role in Abdominal Aortic Aneurysms Mortality Examined - More from this issue of Cardiovascular Device Liability Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
